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In biomedical applications, the development of methodologies to
detect and quantify proteins, speciﬁcally protein biomarkers, has in-
creasingly become essential for areas such as clinical analysis, detection
and treatment of certain diseases that can be correlatedwith changes in
concentration of a protein biomarker in biological ﬂuids. Determining
the amounts of speciﬁc proteins in a given sample is particularly inter-
esting and challenging. These proteins are effective diagnostic and prog-
nostic tools for many diseases depending on the capability of easily
quantifying their low concentrations in biological samples (Csordas et
al., 2010; Hanash, 2011). Several strategies have been pursued to devel-
op accurate and simple diagnosis methodologies, using different recog-
nition elements (e.g. antibodies, aptamers) and different sensing
principles and techniques (e.g. optical, electrochemical). Up to now, a
variety of aptamers exhibiting high selectivity and afﬁnity towards rel-
evant protein disease biomarkers have been reported, thus allowing the
fabrication of new, simple and sensitive diagnostic methods to deter-
mine such proteins in standard solutions and in complex samples
such as blood and serum. The use of electrochemical aptasensors is par-
ticularly interesting given their simplicity, sensitivity, speciﬁcity and
suitability for the detection of low levels of protein disease biomarkers
using several available techniques including cyclic voltammetry (CV),
square-wave voltammetry (SWV) and differential pulse voltammetry
(DPV). Commonly, thrombin is used as a model protein in the design
of aptasensors. However, other disease-related proteins such as plate-
let-derived growth factor (PDGF), osteopontin (OPN), vascular endo-
thelial growth factor (VEGF) and Mucin 1 (MUC1) have been broadly
described. These proteins can be associated to several diseases and
have been found in many cancers, but particularly in breast cancer.
Globally, cancer is a relevant health risk given the amount of persons an-
nually diagnosed with this disease, thus progress leading to enhanced
survival is a global priority. For instance, breast cancer is the most prev-
alent cancer in women worldwide and its cancer-related mortality is
closely associated with the metastatic potential of the primary tumor
(Xu et al., 2015), accounting for 25% (1.67 million) of the all cancer
cases and 15% (522,000) of the cancer deaths. Despite the efforts to re-
duce the number of cases, breast cancer metastasis and breast cancer–
related mortality, the prognosis remains poor (Xu et al., 2015), thus re-
inforcing the relevance of developing new diagnostic methodswith im-
proved features, including high speciﬁcity and sensitivity, low cost,
suitability for prognosis and disease monitoring. Therefore, in this re-
view, a special emphasis is given to the potential use of electrochemical
aptasensors for the detection of protein disease biomarkers (e.g. breast
cancer biomarkers) using voltammetry techniques.
2. Aptamer-based biosensors: aptasensors
According to the International Union of Pure and Applied Chemistry
(IUPAC) “a biosensor is a self-contained integrated device which is ca-
pable of providing speciﬁc quantitative or semi-quantitative analyticalFig. 1. Schematic illustration of a biosensor. The bioreceptor is immobilized on the surface of t
target molecule) is then transformed into a measurable signal by the transducer, which leads tinformation using a biological recognition element (biochemical recep-
tor) which is in direct spatial contact with a transducer element”
(Thévenot et al., 1999, 2001). Another deﬁnition commonly used for
biosensors is “analytical devices that are based on a bioreceptor and
that are capable of sensing biologically-relevant analytes with either
electrical or optical readout” (Cheng et al., 2009). As illustrated in Fig.
1, the main components of biosensors are the bioreceptors or
biorecognition elements; transducers or the detection devices; and dis-
plays or electronic parts comprised by a signal ampliﬁer and the data
processor (Cheng et al., 2009; Strehlitz et al., 2008; Velusamy et al.,
2010). The basic principle of the biosensor detection is the speciﬁc bind-
ing of the target of interest to the bioreceptor immobilized on a suitable
support matrix, usually an electrode, to produce either discrete or con-
tinuous signals,which are proportional to a property of a single target or
a related group of analytes. The signals are then transformed into a dig-
ital format that can be recognized by the end users (Strehlitz et al.,
2008). The bioreceptor will be responsible for the selectivity/speciﬁcity
of the sensor response to a given target or group of targets of interest,
thus minimizing the interference from other substances in complex
mixtures (Viswanathan and Radecki, 2008). On the other hand, the
transducer determines the sensitivity of the biosensor and is responsi-
ble for converting the biological signal into a measurable signal
(Monošík et al., 2012; Sassolas et al., 2009). The selectivity and sensitiv-
ity of the bioreceptor and transducer make the biosensors an attractive
analytical tool in several areas and applicable to a large variety of sam-
ples including body ﬂuids, food, cell cultures and environmental sam-
ples (Cheng et al., 2009; Grieshaber et al., 2008; Sassolas et al., 2009).
Biosensors that use DNA or RNA aptamers as bioreceptors have been
named “aptasensors” (Cheng et al., 2009; Hianik andWang, 2009; Radi,
2011; Sassolas et al., 2009). The aptasensors emerged in the early 1990s
with the discovery and introduction of aptamers as sensing probes
(Ellington and Szostak, 1990; Tuerk and Gold, 1990 cited in Cheng et
al., 2009). Indeed, these were then considered an important alternative
to the classical analytical methods for protein detection. Aptamers are
short nucleic acids (≈12–80 nucleotides long) of RNA or single-strand-
ed DNA that possess unique binding characteristics to their targets, such
as high sensitivity/afﬁnity, speciﬁcity and ability to fold into numerous
tertiary conformations (e.g. hairpin, G-quartet, stem-bulge, pseudoknot,
T-junction) (Cho et al., 2009; de-los-Santos-Álvarez et al., 2008;
Famulok and Mayer, 2011; Lakhin et al., 2013; Meyer et al., 2011;
Radom et al., 2013). Several aptamers have been selected against a
large variety of targets including proteins, ions, toxins, drug molecules,
cells, and tissues (Lee et al., 2008; Shamah et al., 2008; Stoltenburg et
al., 2007), through an in vitro selection procedure known as SELEX (Sys-
tematic Evolution of Ligands by Exponential Enrichment) (Fig. 2).
The SELEX methodology starts with a chemically synthesized ran-
dom oligonucleotides library (up to 1015 different sequences). As illus-
trated in Fig. 2, the selection process may be divided into 3 steps,
namely binding, separation/partitioning and ampliﬁcation,which are it-
eratively repeated to obtain nucleotides with improved binding ability
towards the desired target. After a number of cycles (generally 5–he transducer (signal converter). The binding event (i.e. binding of the bioreceptor to the
o a measurement unit within the electronic device.
Fig. 2. Systematic Evolution of Ligands by Exponential Enrichment (SELEX) methodology.
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binding afﬁnity, secondary structure and Gibbs energy are evaluated
in order to select the aptamers with high afﬁnity and speciﬁcity to the
target molecule (Darmostuk et al., 2015; Dua et al., 2011; Radom et
al., 2013; Santosh and Yadava, 2014; Song et al., 2012; Syed and
Pervaiz, 2010; Vikesland and Wigginton, 2010). The speciﬁc properties
of aptamers as bioreceptors in the development of aptasensors offer
some advantages overmethods that aremainly based on standard afﬁn-
ity receptors (e.g. antibodies), such as high selectivity and afﬁnity, easier
artiﬁcial synthesis, chemical stability under a wide range of buffer con-
ditions, resistance to harsh treatments without loss of bioactivity, re-
versible thermal denaturation, adaptability to various targets, ease of
storage, and versatility in labeling, immobilization, signaling and regen-
eration (Feng et al., 2008; Hianik andWang, 2009; Li et al., 2011a; Radi,
2011; Strehlitz et al., 2008). Indeed, the small size of aptamers allows
their efﬁcient immobilization at high densities in different surfaces.
Thus, production, miniaturization, integration and automation of bio-
sensors can be accomplishedmore easily with aptamers thanwith anti-
bodies (Strehlitz et al., 2008). Altogether these properties make
aptamers an appropriate tool in the development of aptasensors
(de-los-Santos-Álvarez et al., 2008; Guo et al., 2008; Hianik and Wang,
2009; Lee et al., 2008; Park et al., 2009; Song et al., 2008, 2012;
Tombelli et al., 2005; Velasco-Garcia and Missailidis, 2009; Zhang and
Chen, 2010). Additional advantages include the possibility of
performing several analysis withmild changes of the binding speciﬁcity
and selectivity; along with the possibility of using different designs and
detection strategies for fast and easy detection of protein in real biolog-
ical samples (Cheng et al., 2009; Hianik and Wang, 2009; Hianik et al.,
2007; Kim et al., 2008; Nguyen et al., 2009; Song et al., 2008; Zhou et
al., 2011). The lack of speciﬁc aptamers for the majority of protein dis-
ease biomarkers, as well as the existence of few aptamers with two rec-
ognition sites for a single target, may limit the development of
aptasensors. Nevertheless, over the years with the use of different
SELEX methodologies, a large number of aptamers have been isolated
and used to develop aptasensors for the detection of small molecules
and protein disease biomarkers.
The large scale production of aptasensors is subject to some hurdles
that must be overcome, such as the aptamer stability during immobili-
zation and the signal detection in complex biological samples, mainly
due to the interferences from other molecules that are also present in
those samples (Hianik andWang, 2009; Hianik et al., 2007). In biosens-
ing applications, DNA aptamers are suitable for designing reusableaptasensors, whereas RNA aptamers allow single shot measurements
since they are more susceptible to nucleases attack (Sassolas et al.,
2009; Strehlitz et al., 2008). However, some chemical modiﬁcations
can enhance nuclease resistance (i.e. aptamers biostability in serum)
and increase the half-life of aptamers (Kuwahara and Sugimoto, 2010;
Stoltenburg et al., 2007).
In summary, the detection of cancer biomarkers at an early stage al-
lows a better diagnosis, together with the deﬁnition of more adequate
treatments that ultimately will lead to an increased survival. The selec-
tion and design of aptamers that are speciﬁc to recognized cancer bio-
markers (e.g. OPN, MUC1, VEGF) can represent a good alternative for
diagnostic and treatment of the disease. In this review some electro-
chemical transducers for the detection of proteins are discussed, as
well as methods of immobilization of aptamers and the detection strat-
egies used in the production of electrochemical (voltammetric)
aptasensors.
3. Electrochemical aptasensors
Electrochemical aptasensors use an electrode surface to immobilize
the aptamer and hold an electrochemical transducer to monitor the
aptamer-target interaction, by detecting current or potential changes
that occur at the transducer/bioreceptor interface/surface (Hong et al.,
2012; Monošík et al., 2012; Sadik et al., 2009; Thévenot et al., 1999,
2001). The electrochemical transduction presents considerable advan-
tages over optical, piezoelectric or thermal detection (Deng et al.,
2013a; Radi, 2011), such as high sensitivity and selectivity, the ability
to work with turbid samples, compatibility with novel microfabrication
technologies, inherent miniaturization, disposability and accuracy, sim-
plicity, robustness, possibility of usage for on-line control, fast response,
and relatively low manufacturing cost; thus making electrochemical
aptasensors extremely attractive for diagnostic and use in point-of-
care devices, in addition to simultaneous multi-analyte detection
(Arshak et al., 2009; Radi, 2011; Saberian et al., 2011; Song et al.,
2008; Velasco-Garcia and Missailidis, 2009; Velusamy et al., 2010; Xu
et al., 2009).
The ﬁrst aptasensor for the detection of a target protein at
nanomolar levels was reported in 1998, using a DNA aptamer against
thrombin (as previously mentioned, a model protein commonly used
in the design of aptasensors) (Potyrailo et al., 1998 cited by Zhou et
al., 2011). Later, Hianik et al. (2005) described the ﬁrst voltammetric
aptasensor using DNA aptamers against thrombin immobilized onto a
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interactions through themeasurement of charge changes by differential
pulse voltammetry (DPV) and using methylene blue (MB) as the elec-
trochemical indicator. The electrochemical transduction of biosensors
using aptamers as bioreceptors can be divided in voltammetric, amper-
ometric, potentiometric, impedimetric and conductometric, depending
on the measurable parameters such as current and potential, current,
potential, impedance, and conductance, respectively (Arshak et al.,
2009; Velusamy et al., 2010). Among voltammetric biosensors, different
voltammetry techniques can be used such as CV, DPV, SWV and alter-
nating current voltammetry (ACV). The voltammetric and/or ampero-
metric biosensors are characterized by applying a potential to a
working electrode versus a reference electrode. The corresponding cur-
rent is a result of electrolysis by means of an electrochemical reduction
or oxidation at theworking electrode. Amperometric biosensorsmay be
considered a subclass of voltammetric biosensors since they operate
under an imposed constant potential (voltage) that is maintained at
the working electrode with respect to a reference electrode, being the
change in current monitored as a function of time. On the other hand,
in the voltammetric biosensors the potential is scanned over a set po-
tential range and both the current and potential are measured and re-
corded. For amperometric and voltammetric biosensors, the recorded
current response is proportional to the concentration of the target mol-
ecule in the sample (Grieshaber et al., 2008; Kumar and D'Souza, 2012;
Liu, 2000; Rahman et al., 2008; Ronkainen et al., 2010; Viswanathan and
Radecki, 2008). A remarkable advantage of voltammetric biosensors is
the low related noise observed, hence providing reliable and reproduc-
ible data for the quantiﬁcation of a target molecule, which can endow
the biosensor with higher sensitivity and speciﬁcity. In addition, volt-
ammetry allows the detection of multiple compounds, which have dif-
ferent peak potentials, in a single electrochemical experiment (or
scan), thus offering the possibility of simultaneously detecting multiple
analytes (Marks and Abdulhalim, 2015). Among the voltammetric
aptasensors, those based on CV, DPV and SWV are the most frequently
used. However, the CV technique can be used to evaluate the electrode
surface, namely its purity, stability, reproducibility and repeatability. CV
may also be used for cleaning and for monitoring the immobilization of
aptamers on the electrode surface since it allows a fast visualization of
the redox behavior over a wide potential range (Ferreira et al., 2011).
Moreover, it can also be used to study the performance of an electro-
chemical aptasensor during the detection of several molecules, such as
proteins (Cheng et al., 2007; Meirinho et al., 2015; Wang et al., 2009;
Yuan et al., 2011).
The electrochemical aptasensors can be applied in several areas such
as health (speciﬁcally in clinical diagnostic and for therapeutic pur-
poses), food industry and environmental monitoring for the detection
of protein disease biomarkers, pathogens and small molecules, respec-
tively (Hayat and Marty, 2014; Hong et al., 2012; Kim and Gu, 2014;
Labib and Berezovski, 2014; Liu et al., 2012; Palchetti and Mascini,
2012; Sett et al., 2012). The application of electrochemical aptasensors
for clinical diagnosis, particularly for the detection of protein disease
biomarkers, which is an emergent ﬁeld of research, is herein discussed
as previously mentioned.
3.1. Electrode surface
The electrode/transducer surface (e.g. thickness and stability of the
materials), the immobilization method and the detection technique
are relevant factors that must be considered whenever developing an
electrochemical aptasensor (Zhang et al., 2000). Usually, a three-elec-
trode conﬁguration is included in the surface of a voltammetric
aptasensor, namely the working, auxiliary or counter and the reference
electrodes (Lim et al., 2010). The commonmaterial used as theworking
electrode surface is carbon and noble metals, for which different immo-
bilization strategies and detection approaches can be applied. Metals
such as gold, platinum, silver and stainless steel have long been usedfor electrochemical electrodes due to their excellent electrical and me-
chanical properties (Hayat and Marty, 2014; Ronkainen et al., 2010;
Zhang et al., 2000). Other electrode surfaces can be used in the develop-
ment of electrochemical aptasensors, such as screen printed electrodes
(SPE), glassy carbon electrodes (GCE), carbon paste electrodes (CPE),
depending on the target molecule to be detected. The use of the latter
allows the miniaturization of the biosensor, as well as reducing the vol-
ume of samples and reagents down to a few microliters. In addition,
these sensors avoid the contamination between samples and exhibit a
reproducible sensitivity (Ronkainen et al., 2010; Tothill, 2009; Wei et
al., 2009).
3.2. Immobilization of the aptamers
Another essential step in the development of electrochemical
aptasensors is the immobilization of the aptamer, which plays a major
role in the overall biosensor performance. The stability, afﬁnity and
speciﬁcity of the aptamer towards the target molecule depend on the
technique used to immobilize it onto the electrode/transducer surface.
Thus, it is crucial to treat and control the surface to assure high reactiv-
ity, orientation/accessibility and stability of the surface-bound aptamer,
as well as to minimize non-speciﬁc binding/adsorption phenomena
(Hianik and Wang, 2009; Lim et al., 2010). The choice of the immobili-
zation method depends on several factors, such as the nature of the
bioreceptor and electrode/transducer surface, the physicochemical
properties of the target molecule and the operating conditions of the
biosensor. Therefore, the selected method should ensure that the bind-
ing afﬁnity and selectivity of the aptamers in solution are kept in order
to obtain the maximum activity whenever they are immobilized as the
bioreceptor (Balamurugan et al., 2008; Velasco-Garcia and Missailidis,
2009). The immobilization methods usually applied are physisorption
(physical adsorption), chemisorption (chemical adsorption),
streptavidin/avidin/neutravidin-biotin interaction and covalent attach-
ment via functional groups (Balamurugan et al., 2008;
de-los-Santos-Álvarez et al., 2008; Sassolas et al., 2009; Zhou et al.,
2011) (Fig. 3). In the ﬁrst method, no aptamer modiﬁcation is required
and the aptamer is immobilized on the electrode surface by means of
electrostatic forces. This method is simple but, in general, it is not suit-
able for the development of reusable aptasensors due to the low stabil-
ity resulting from the aptamers' desorption from the surface (Hianik
and Wang, 2009; Paniel et al., 2013; Radi, 2011; Sassolas et al., 2009).
In the other three methods, the aptamers are modiﬁed with a thiol
group (–SH), a biotin protein and a chemical functional group (e.g.
amino groups (–NH2)), respectively (de-los-Santos-Álvarez et al.,
2008; Zhou et al., 2011). Aptamers can be modiﬁed and attached to
the electrode surface either by the 5′-end or the 3′-end. Both positions
have been used to develop aptasensors, although very few studies eval-
uated the effect of the type of the aptamer's end position, used for the
attachment to the surface, on the immobilization and aptasensor perfor-
mances. However, some studies suggest that it depends on the particu-
lar aptamer, although the 3′-end could be more suitable for biological
targeting since it is the primary target for exonucleases and its binding
to the solid support would simultaneously confer resistance to nucle-
ases (Hayat and Marty, 2014; Hianik and Wang, 2009; Velasco-Garcia
and Missailidis, 2009). These immobilization methods allow obtaining
a stable, ﬂexible and repeatable aptamer layer on the surface (Radi,
2011; Xu et al., 2009; Zhou et al., 2011).
The chemisorption method consists in the direct immobilization of
the thiolated aptamer onto the electrode surface. It is a simple and effec-
tive method based on the strong afﬁnity of thiol groups (–SH) for gold
electrode surfaces that enables the formation of covalent bonds be-
tween the sulfur and gold atoms forming a stable and ﬂexible self-as-
sembled monolayer (SAM) with repeatable aptamer surface layers
(Paniel et al., 2013; Sassolas et al., 2009).
The immobilization of aptamers based on the streptavidin/avidin/
neutravidin-biotin interaction has been exploited based on the speciﬁc
Fig. 3. Immobilization methods of aptamers onto gold electrode surfaces for the development of electrochemical aptasensors. A) Physical adsorption: immobilization based on charge-
charge interaction or hydrophobic interactions occurring between the negatively charged groups present on the DNA probe and positive charges covering the surface; B)
chemisorption: thiolated aptamer attached to the gold electrode via a covalent bond between the sulfur and gold atoms; C) streptavidin-biotin interaction: biotinylated aptamer
immobilization throw a speciﬁc streptavidin-biotin interaction; D) covalent attachment: aptamer modiﬁed with amine group covalently bonded to functionalized gold electrode with
a functional group (e.g. an carboxylic acid group).
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streptavidin and avidin proteins have four identical binding sites for bi-
otin (Chung et al., 2011; Hayat and Marty, 2014). However, the
streptavidin is preferably used over avidin, leading to fewer non-speciﬁc
interactions associated to the low isoelectric point (pI) (Lim et al., 2010;
Sassolas et al., 2008, 2009). The streptavidin (or derivatives) can easily
be linked on the electrode surface through physical adsorption or non-
covalent bonding (Hianik et al., 2005, 2007; Nimse et al., 2014; Zhou
et al., 2011). Other advantages can be pointed out, namely the need of
very low amounts of biotinylated aptamer (Chung et al., 2011); the
fact that it is less affected by changes of buffer concentration, pH, dena-
turants and high temperatures; as well as the decrease of non-speciﬁc
adsorption and improvement of the signal-to-noise ratio (Paniel et al.,
2013; Zhou et al., 2011).
In the covalent attachment method, the electrode surfaces are mod-
iﬁedwith chemical groups (e.g. amine: –NH2; hydroxyl: –OH; carboxyl-
ic acid: –COOH; aldehyde: –CHO) that interact with the modiﬁed
aptamer exhibiting the corresponding chemical functional group to
form an ordered aptamers layer on the electrode surface. Commonly,
the amino (–NH2)-modiﬁed aptamer is covalently attached onto the
electrode surface functionalizedwith thiolic acids and then the terminal
carboxylic group (–COOH) is activated with 1-ethyl-3-[3-
dimethylaminopropyl]-carbodiimide hydrochloride (EDC)/N-
hydroxysulfosuccinimide (sulfo-NHS) (Balamurugan et al., 2008; Zhou
et al., 2011). This method can be performed on different surfaces such
as gold or platinum electrodes, glassy carbon, carbon pasta, silicate
and polymer surfaces and, more recently, gold nanoparticles (AuNPs)
and gold nanorods (AuNRs) (Zhou et al., 2011). However, the choice
of the surface functionalization strategy to be implemented depends
on the type of terminal functional groups linked to the aptamer
(Balamurugan et al., 2008). This method allows increasing the speciﬁc-
ity of the aptasensors and decreasing the non-speciﬁc adsorption
(Paniel et al., 2013).
Another method that can be used is the application of the partially
complementary sequences that are immobilized onto the electrode sur-
faces using one of the methods described above. In this case, the
aptamers are immobilized by hybridization. However, in this method
the experimental conditions are difﬁcult to control since it involves an-
nealing and hybridization steps (Han et al., 2009; Hianik and Wang,
2009). Whenever manufacturing aptasensors, it is important to evalu-
ate how the immobilization methods can affect their performance re-
garding the detection of the target molecule. Hianik et al. (2007)
evaluated the sensitivity of aptasensors using three aptamer immobili-
zation methods, namely the bonding through afﬁnity (avidin-biotin in-
teraction), direct chemisorption of aptamers modiﬁed with -SH groups
and polyamidoamine (PAMAM) dendrimers layers. The best resultswere obtained for the aptamer immobilization by means of avidin-bio-
tin interaction, followed by the dendrimer layer and lastly the aptamer
chemisorbed directly onto the gold surface. Similarly, Ostatná et al.
(2008) demonstrated that the immobilization of the aptamers by
means of the streptavidin-biotin interaction showed the best results re-
garding the sensor speciﬁcity and sensitivity.
3.3. Design strategies
Different design strategies may be adopted in the fabrication of elec-
trochemical aptasensors depending on the envisaged use. These strate-
gies (reviewed by Cheng et al. (2009) and Han et al. (2010)) can be
divided into three or four types based on the differences in the design
of theDNA/RNA-modiﬁed electrodes. Cheng et al. (2009) classiﬁed elec-
trochemical aptasensors in three categories in which the analyte/target
molecule detection relies on a conﬁguration change (i.e. target binding
induces either an assembly or dissociation of the aptamer); conforma-
tion change (i.e. target binding induces a modiﬁcation in the conforma-
tion of the aptamer immobilized onto the surface); and conductivity
change (i.e. target binding “switches on” the conductivity of the sur-
face-bound aptamer–DNA). On the other hand, Han et al. (2010) sug-
gested four possible design strategies, viz. target-induced structure
switching mode; sandwich or sandwich-like mode; target-induced dis-
sociation or displacement mode; and competitive replacement mode.
Fig. 4 illustrates the main strategies/designs used in the development
of electrochemical aptasensors. Regarding the electrochemical
aptasensors detection, two main approaches have been used, namely
the label (using labelled aptamers) and label-free (using non-labelled
aptamers) approaches. The measurement of changes in the electrode
surface of electrochemical aptasensors can be either “signal-on” (posi-
tive readout signal) or “signal-off” (negative readout signal), i.e. an in-
crease or a decrease of the response following upon aptamer-target
interaction, depending on the format of the assay used in the aptasensor
fabrication (Hayat and Marty, 2014; Radi, 2011; Sassolas et al., 2009;
Song et al., 2008; Strehlitz et al., 2008). However, the aptasensors
based in “signal-off” are usually less sensitive,more susceptible to back-
ground variation and small signal changes (Zhou et al., 2014). In the lit-
erature, the detection “signal-on” or “signal-off” is usually associated
with target binding-induced aptamer conformational change (Baldrich
et al., 2006; Lai et al., 2007; Liu et al., 2010; Ma et al., 2013; Sánchez et
al., 2006; Xiao et al., 2005a) and target binding-induced aptamer-com-
plementary sequence dissociation/displacement strategies (Lu et al.,
2008; Xiao et al., 2005b). This is due to the fact that aptamer-label or
aptamer-complementary sequence-label after binding to its target pro-
motes the approximation of the label on the electrode surface, thus in-
creasing the current (“signal-on”) or a distancing of the label from the
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al., 2009). However, this classiﬁcation “signal-on” and “signal-off”, is
also often employed in the sandwich assays (Centi et al., 2007, 2009;
Zhang et al., 2007, 2009) or label-free aptasensors, when an increase
or decrease of the signal is observed after the formation of the
aptamer-target complex (Cheng et al., 2007; Degefa and Kwak, 2008;
Meirinho et al., 2015; Rodríguez and Rivas, 2009).
Thrombin has been the most used protein to study electrochemical
aptasensors. Its detection is crucial inmany areas of biomedical research
and diagnostic, as it is a multifunctional serine protease, whose concen-
tration level in blood has high relevance in some pathologies (Wang et
al., 2011). Therefore, the strategies used for the detection of thrombin
can be a starting point for the development of similar strategies to de-
tect many other cancer-related proteins (e.g. PDGF, OPN, VEGF, MUC1).
3.4. Labelled electrochemical aptasensors
In the labelled approaches, the bioreceptor can be labelled with a
great variety of different redox compounds. These redox compounds
can be covalently bound to the aptamer andmodulate the electrochem-
ical signal upon formation of the aptamer–target complex (Hayat and
Marty, 2014; Palchetti and Mascini, 2012; Prieto-Simón et al., 2010;
Sassolas et al., 2009). The aptamers can be labelled at both 3′- and 5′-
ends. At one end, for immobilization at the electrode surface and at
the other end, the redox compounds for signal ampliﬁcation (Strehlitz
et al., 2008). The horseradish peroxidase (HRP), glucose oxidase
(GOD) and alkaline phosphatase (AP) enzymes can also be used as
redox compounds (Prieto-Simón et al., 2010). However, the most com-
monly used are ferrocene (Fc), MB and recently nanomaterials such as
quantum dots (QDs) and nanoparticles (NPs), which present some ad-
vantages over the enzymes for biosensing assays (Hayat and Marty,
2014). Table 1 compiles some of the most relevant works that report
the development of labelled electrochemical aptasensors using
voltammetric techniques for the detection of speciﬁc proteins. The elec-
trochemical cell, aptamer immobilization technique, redox compounds,
design and detection assay type, detection limit, working range and ap-
plications are described for each example.
3.4.1. Aptasensors based on target binding-induced aptamer conformation
Xiao et al. (2005a) developed a labelled “signal-off” electrochemical
aptasensor for the detection of thrombin in blood serum. Before binding
the protein, the 3′-end MB-label aptamer is close to the electrode sur-
face, thus allowing the transfer of electrons with the electrode surface
due to the ﬂexible structure of the aptamer. After thrombin binding,
the aptamer forms a stable and rigid structure (G-quadruplex structure)
and the MB-label is kept away from the electrode surface, the electron
transfer is inhibited, resulting in a current decrease. The electrochemical
measurements were performed by ACV and a low detection limit ofFig. 4. Strategies to develop electrochemical aptasensors. A) Target binding-induced
aptamer conformation change. A1) “Signal-off”: the aptamer sequence remained
unfolded, in the absence of target, and the redox moiety is close to the electrode surface;
upon binding target, the aptamer changes the structure, displacing the redox moiety
away from the gold electrode inhibiting the electron transfer process. A2) “Signal-on”:
inverse situation as the one referred as “signal-off”, where upon aptamer-target binding,
the aptamer's conﬁguration changes displacing the redox moiety close to the electrode
surface; B) target binding-induced aptamer-complementary sequence dissociation/
displacement. B1) “Signal-off”: the aptamer immobilized onto the gold surface forms a
double-stranded construct with a cDNA sequence labelled with redox moiety that is
proximal to gold surface, allowing an efﬁcient electron transfer between redox and gold
surface, which is inhibited in the presence of the aptamer-target bound due to the
release of the cDNA sequence. B2) “Signal-on”: the labelled cDNA sequence immobilized
onto the gold surface forms a double helix with an aptamer sequence, displacing the
redox moiety away from the electrode; the unfolded cDNA sequence was obtained upon
aptamer-target bound, displacing redox moiety close to the electrode surface promoting
the electron transfer and signal increase; C) sandwich assays: two aptamers are used for
target detection, one is immobilized onto the gold surface and the other is labelled with
a redox moiety, resulting in dual binding sites for the target, allowing the formation of
an aptamer-target-aptamer structure that promotes the electron transfer.
Table 1
Labelled electrochemical aptasensors using voltammetric techniques for the detection of protein disease biomarkers.
Change
response
Target/
aptamers
Electrochemical
cells
Aptamer
immobilization
Redox
compounds
Electrochemical
technique
Assay type Detection
limit (LOD)
Working/linear
range
Application Reference
Signal-off Thrombin
(DNA)
WE: Au
RE: Ag/AgCl
AE: Pt wire
5′-End thiolated;
chemisorption
3′-End MB
label
aptamer
ACV Target
binding-induced
aptamer
conformational
change
6.4 nM 50–768 nM Thrombin
detection in
blood serum
Xiao et al.
(2005a)
IFN-γ
(DNA)
WE: Au; RE:
Ag/AgCl
AR: Pt wire
5′-Thiolated;
chemisorption
3′-End MB
label
aptamer
SWV Target
binding-induced
aptamer
conformational
change
0.06 nM Up to 10 nM IFN-γ
detection
Liu et al.
(2010)
MUC 1
(DNA)
WE: Au
RE: Ag/AgCl
AE: Pt
5′-Thiolated;
chemisorption
3′-End MB
label
aptamer
SWV Target
binding-induced
aptamer
conformational
change
50 nM Up to 1.5 μM MUC1
detection
Ma et al.
(2013)
VEGF WE: Au disk
RE: Ag/AgCl
AE: Pt
5′-Thiolated;
chemisorption
3′-End MB
label
aptamer
ACV Target
binding-induced
aptamer
conformational
change
5 pM 50–150 pM VEGF
detection in
human
whole blood
Zhao et
al.
(2011b)
TNF-α
(RNA)
WE: Au
RE: Ag/AgCl
AE: Pt wire
5′-Thiolated;
chemisorption
5′-End MB
label
aptamer
SWV Target
binding-induced
aptamer
conformational
change
50 pM Up to 6 nM TNF-α
detection in
blood
Liu et al.
(2013)
Signal-on Thrombin
(DNA)
WE: Au
RE: Ag/AgCl
AE: Pt
3′-End thiolated;
chemisorption
5′-End Fc
label
aptamer
DPV Target
binding-induced
aptamer
conformational
change
0.5 nM 5–35 nM Thrombin
detection
Radi et al.
(2006)
Thrombin
(DNA)
WE: Au
RE: Ag/AgCl
AE: Pt wire
3′-End thiolated;
chemisorption
5′-End Fc
label
aptamer
SWV Target
binding-induced
aptamer
conformational
change
1 nM 1–35 nM Thrombin
detection
Sánchez
et al.
(2006)
Thrombin
(DNA)
WE: carbon
RE: Ag
AE: carbon
Two 5′-end
biotinylated;
streptavidin-biotin
interaction.
AP
conjugated
secondary
aptamer
DPV Sandwich
(APT1/THR/APT2)
0.5 nM ND Thrombin
detection in
serum
Centi et
al. (2007)
PDGF-BB WE: Au
RE: Ag/AgCl
AE: Pt wire
5′-End thiolated;
chemisorption
3′-End MB
label
aptamer
ACV Target
binding-induced
aptamer
conformational
change
1 nM (blood
serum); 50
pM (diluted
serum)
ND PDGF
detection in
blood serum
Lai et al.
(2007)
PDGF-BB
(DNA)
WE: Au
RE: SCE
AE: Pt
5′-End thiolated;
chemisorption
3′-End Fc
label
attached
secondary
aptamer
DPV Sandwich
(APT1/THR/APT2)
39.37 fM 39.37
fM–39.37 pM
PDGF-BB
detection
Zhang et
al. (2007)
C-reactive
protein
(CRP)
(RNA)
WE: carbon
RE: Ag
AE: carbon
5′-End
biotinylated;
streptavidin-biotin
interaction
AP
conjugated
biotinylated
antibody
DPV Sandwich
(APT/CRP/antibody)
2 nM (free
serum)
1 nM–0.5 μM CRP
detection in
free serum
and serum
samples
Centi et
al. (2009)
Note: ACV (alternating-current voltammetry); AE (auxiliary electrode); Ag (silver); Ag/AgCl (silver/silver chloride); AP (alkaline phosphatase); APT 1 (aptamer 1); APT 2 (aptamer 2); Au
(gold); CRP (C-reactive protein); DPV (differential pulse voltammetry); Fc (ferrocene); IFN-γ (Interferon gamma); MB (methylene blue); MUC1 (Mucin 1); ND (not deﬁned); PDGF
(platelet-derived growth factor); Pt (platinum); RE (reference electrode); SCE (saturated calomel electrode); SWV (square wave voltammetry); THR (thrombin); TNF-α (tumor necrosis
factor alpha); VEGF (vascular endothelial growth factor); WE (working electrode); units converted to Molar taking into account the molecular weight 25.4 kDa (PDGF-BB).
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proaches for diagnosis purposes. Likewise, Liu et al. (2010) developed
a label “signal-off” aptasensor for the detection of interferon gamma
(IFN-γ). The aptamer against IFN-γ was 5′-end thiolated, conjugated
with 3′-MB-label and immobilized on a gold electrode surface. The
IFN-γ binding induced an aptamer conformation change, increased
the distance ofMB-label from the electrode surface and led to a decrease
of the electron transfer and consequently of the current. The SWV was
used to quantify the current decrease and a very low detection limit
was achieved. This labelled “signal-off” electrochemical aptasensor
proved to be sensitive and speciﬁc to IFN-γ in the presence of overabun-
dant serum protein. The authors used the same strategy (Liu et al.,2013) for the detection of TNF-α also using a RNA aptamer modiﬁed
with the thiol group andMB-label for immobilization and ampliﬁcation
of signal, respectively. Similarly, in this case the aptasensor detected the
target protein (TNF-α) in blood samples with good sensitivity. Ma et al.
(2013) developed a labelled “signal-off” electrochemical aptasensor to-
wards another protein biomarker, MUC1, which is a glycoprotein impli-
cated in some cancers, as breast cancer. The thiolated DNA aptamer was
immobilized onto a gold electrode surface and the other aptamer end
was labelled with MB to enable the electrochemical measurements. In
the absence of MUC1, one hairpin structure was formed and the elec-
trode transfer between MB-label and the gold electrode was facilitated.
Upon MUC1 binding, a conformational change of the aptamer was
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decrease in the current was observed. This electrochemical aptasensor
showed good speciﬁcity in the presence of other proteins and could be
seen as a very promising tool in clinical applications. Using the same
type of labels (thiol- and MB-modiﬁed DNA aptamer), Zhao et al.
(2011b) developed an aptasensor for the detection VEGF in blood
serum and whole blood. Upon VEGF binding, the partially unfolded
aptamer formed a conformational restrict stem-loop structure. This
conformational change forces the MB label to be in the close proximity
of the electrode, thus resulting in a signiﬁcant increase of the electron
transfer and current signal. An outstanding detection limit of 5 pM
(190 pg/mL) was achieved in 50% of blood serum. In the same work, a
gold-plated screen-printed carbon electrode was tested showing a sim-
ilar performance.
Sánchez et al. (2006) and Radi et al. (2006) implemented the target
binding-induced aptamer conformation principle to develop “signal-
on” electrochemical aptasensors to detect thrombin. The aptamers
weremodiﬁedwith Fc and SWV or DPVwere used for the electrochem-
icalmeasurements, respectively. In both reports the detection limits ob-
tained were very low (lower than the signal-off reported by Xiao et al.
(2005a)), again suggesting the potential of these biosensors. Using the
same strategy, Lai et al. (2007) reported a labelled “signal-on” electro-
chemical aptasensor for the detection of platelet-derived growth factor
B-chain (PDGF-BB) in clinical samples. The aptasensor was constructed
by immobilizing a MB-label aptamer onto a gold electrode surface
through a thiol group. In the absence of PDGF-BB, the MB-label is far
away from the electrode surface. Upon PDGF-BB binding, the aptamer
forms a stable structure holding theMB-label close to the electrode sur-
face, improving the electron transfer. The ACV was used to monitor the
changes at the electrode surface and a detection limit of 1 nM was ob-
tained in blood serum and of 50 pM in serum 2-fold diluted with buffer.
This aptasensor showed excellent stability in real samples and could be
regenerated by disrupting aptamer-PDGF-BB.
3.4.2. Aptasensors based on sandwich design
Apart from the target binding-induced aptamer conformational
change, other designs have been explored to develop electrochemical
aptasensors. The sandwich format presents an increased sensitivity
and selectivity concerning the detection of the target molecule. Howev-
er, two conditions are required for this sensor arrangement, namely (a)
the targetmust have two independent binding sites (epitopes) towhich
two different ligands (aptamers) may bind the target molecule without
affecting the binding of other targets; and (b) two ormore aptamers are
selected against the target (Han et al., 2010; Palchetti and Mascini,
2012).
In this type of arrangement, generally, one aptamer is immobilized
onto the electrode surface, while the other is used as a label for signal
ampliﬁcation. Very few target molecules (thrombin and PDGF) have
two binding sites and two or more isolated aptamers, which limits the
use of this type of sensor format. However, this limitation can be
circumvented through the use of the two following formats for the de-
sign of an aptasensor, namely the aptamer-protein-aptamer (using the
same aptamer) and aptamer-protein-antibody (Han et al., 2010;
Palchetti andMascini, 2012; Taleat et al., 2014). Commonly, the second-
ary ligands can be labelled with different redox labels such as MB, Fc,
nanomaterials (e.g. NPs) or enzymes (e.g. HRP or AP). Another disad-
vantage of this format is the time consuming steps of incubation
(Palchetti and Mascini, 2012).
Some works have reported the use of the sandwich-format
aptasensor for the detection of different proteins, namely thrombin
(Centi et al., 2007; Ding et al., 2010; Kang et al., 2008; Zhao et al.,
2011a), C-reactive protein (CRP) (Centi et al., 2009) and PDGF (Wang
et al., 2009; Zhang et al., 2007, 2009). Centi et al. (2007) developed a la-
belled “signal-on” electrochemical aptasensor for the detection of
thrombin in complex matrices using the sandwich assay with magnetic
particles as solid supports. Two biotinylated aptamers against thrombinwere used for the aptasensor design. A biotinylated aptamer was cap-
tured onto streptavidin-coated magnetic beads and the resulting
aptamer-modiﬁed magnetic beads were incubated with thrombin.
Upon binding with thrombin, a biotinylated secondary aptamer was
added, which was ready to bind in a further step to a streptavidin–AP
conjugate. A detection limit of 0.5 nM was obtained which is much
lower than the values reported by the other authors previously men-
tioned that developed aptasensors based on target binding-induced
aptamer conformational changes (Lai et al., 2007; Ma et al., 2013;
Sánchez et al., 2006; Xiao et al., 2005a). These authors used the same
strategy for detecting the CRP protein. However, in this case a biotinyl-
ated aptamer with afﬁnity for CRP immobilized onto streptavidin mag-
netic beads (capture probe) and a biotinylated monoclonal antibody
anti-CRP conjugated with alkaline phosphatase (AP) (detection probe)
were used. Again very low detection limits (2 nM) in serum samples
were obtained (Centi et al., 2009). A similar sandwich strategy was de-
signed by Zhang et al. (2007, 2009) to detect the proteins PDGF-BB and
PDGF, respectively. In these works, the detection of the protein targets
was based on the proximity-dependent surface hybridization assay.
Two aptamers that recognize different sites of the protein target were
used. The 5′-end of both aptamers was coupled to a short complemen-
tary sequence. The recognition of the protein by thepair of aptamers en-
abled the hybridization between the complementary sequences of both
aptamer probes, which promotes the proximity of the two tail sequence
of both aptamers and the cooperative annealing of the aptamer-protein-
aptamer complex on capture probes immobilized on the electrode. As a
result, an increase of the redox signal by proximity of Fc-label attached
to the secondary aptamer with the gold electrode was promoted. Out-
standing detection limits for PDGF-BB (1 pg/mL) and PDGF (0.1 ng/
mL) were obtained.
3.5. Label-free electrochemical aptasensors
In the label-free approaches, the bioreceptor is not labelled with
redox compounds (Prieto-Simón et al., 2010; Sassolas et al., 2009;
Strehlitz et al., 2008). The aptamers are immobilized on the electrode
surface and the target-aptamer interaction is detected by electrochem-
ical techniques (such as voltammetry and electrochemical impedance
spectroscopy (EIS)) through electroactive molecules such as ferricya-
nide and ruthenium complexes ([Fe(CN)6]3−/4− and Ru(NH3)6]3+, re-
spectively) that can be electrostatically associated or can diffusively
interact (attraction/repulsion) with the aptamers (Prieto-Simón et al.,
2010). However, in some cases labelled aptamer-complementary se-
quences or MB-intercalate can be used in these approaches
(Prieto-Simón et al., 2010; Sassolas et al., 2009; Strehlitz et al., 2008)
and the changes on the electrode surface can result in target binding-in-
duced aptamer-complementary sequence dissociation/displacement or
target binding-induced aptamer conformational change, respectively.
Table 2 summarizes some relevant studies on electrochemical
aptasensors using voltammetric techniques that have been developed
for speciﬁc protein detection using label-free detection.
3.5.1. Aptasensors based on target binding-induced aptamer conformation
Bang et al. (2005) developed a signal-off electrochemical aptasensor
for the detection of thrombin using the target binding-induced aptamer
conformation principle. In the construction of the aptasensor, a modi-
ﬁed aptamer with MB-label intercalated into the sequence was used,
and this aptamer was covalently attached onto the gold electrode. The
aptamer-thrombin interaction led to the change of the aptamer confor-
mation and consequently to a decrease in the current intensity. This
simple method allowed the detection of thrombin with a detection
limit of 11 nM, which is similar to some of the examples using different
approaches abovementioned. In the same year, Hianik et al. (2005) de-
veloped a signal-on aptasensor also to detect thrombin. The avidin-bio-
tin interaction was used to immobilize the aptamers onto the gold
electrode surface. Thrombin was detected based on the change of
Table 2
Label-free electrochemical aptasensors using voltammetric techniques for the detection of protein disease biomarkers.
Change
response
Target/
aptamer
Electrochemical
cells
Aptamers
immobilization
Redox
compounds
Electrochemical
technique
Assay type Detection
limit (LOD)
Working/linear
range
Application Reference
Signal-off Thrombin
(DNA)
WE: Au
RE: Ag/AgCl
AE: Pt wire
5′-End amine;
covalent
attachment
MB-intercalated
label
DPV Target
binding-induced
aptamer
conformational
change
11 nM Up to 50.8 nM Thrombin
detection
Bang et
al. (2005)
Thrombin
(DNA)
WE: Au
RE: Ag/AgCl
AE: Pt wire
5′-End thiolated;
chemisorption
Fc-short
labelled cDNA
sequence
DPV Target
binding-induced
aptamer-cDNA
sequence
dissociation
2 nM Up to 10 nM Thrombin
detection
Lu et al.
(2008)
PDGF
(DNA)
WE: Au
RE: MSE
AE: Pt wire
5′-Thiolated;
chemisorption
[Fe(CN)6]3−/4− DPV Target
binding-induced
aptamer
conformational
change
ND 1–40 nM PDGF
detection
Degefa
and Kwak
(2008)
Osteopontin
(RNA)
WE: Au;
RE: Ag
AE: Au
5′-End-biotinylated;
streptavidin-biotin
interaction
[Fe(CN)6]3−/4− CV Target
binding-induced
aptamer
conformational
change
3.7 nM 25–2402 nM Osteopontin
detection
Meirinho
et al.
(2015)
Signal-on Thrombin
(DNA)
WE: Au 5′-End thiolated;
chemisorption
MB-attached
partially cDNA
sequence
ACV Target
binding-induced
aptamer-cDNA
sequence
displacement
3 nM Up to 80 nM Thrombin
detection
Xiao et al.
(2005b)
Thrombin
(DNA)
WE: Au
RE: Ag/AgCl
AE: Pt wire
3′-End biotinylated;
streptavidin-biotin
interaction
MB-intercalated
label
DPV Target
binding-induced
aptamer
conformational
change
10 nM ND Thrombin
detection
Hianik et
al. (2005)
VEGF and
MUC1
(DNA/DNA)
WE: Au
RE: SCE
AE: Pt wire
5′-Thiolated cDNA
sequence
Chemisorption
Fc-labelled
cDNA sequence
SWV Hybridization
reaction between
cDNA sequence
and two aptamers
MUC1: 0.33
nM
VEGF: ND
1–20 nM VEGF and
MUC1
detection
Zhao et
al. (2012)
Note: ACV (alternating-current voltammetry); AE (auxiliary electrode); Ag (silver); Ag/AgCl (silver/silver chloride); Au (gold); CV (cyclic voltammetry); DPV (differential pulse voltamm-
etry); Fc (ferrocene); MB (methylene blue); MSE (Hg|HgSO4|K2SO4 (sat) electrode); MUC1 (Mucin 1); ND (not deﬁned); PDGF (platelet-derived growth factor); Pt (platinum); RE (ref-
erence electrode); SCE (saturated calomel electrode); SWV (square wave voltammetry); VEGF (vascular endothelial growth factor); WE (working electrode).
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with DNA aptamer. The detection limit obtained with this aptasensor
was better than the previous example. Degefa and Kwak (2008) report-
ed a label-free approach for detecting the PDGF cancer-related protein
using [Fe(CN)6]3−/4−as a redox probe. The DNA aptamer against
PDGF was self-assembled in a monolayer onto the gold surface which,
in the absence of the PDGF, showed a dynamic state and efﬁcient elec-
tron transfer between the redox probe and the electrode surface. After
PDGF binding-induced aptamer conformation change, the electron
transfer was signiﬁcantly affected and a linear decrease of the peak cur-
rent with the protein concentration was observed. We used a similar
strategy to develop an aptasensor for the detection of OPN, a potential
biomarker for breast cancer (Meirinho et al., 2015). An RNA aptamer
was immobilized on a streptavidin-modiﬁed gold surface through the
streptavidin-biotin interaction. After binding the OPN, the current de-
crease was measured by CV in the presence of [Fe(CN)6]3−/4− that is
the redox probe. The “signal-off” electrochemical aptasensor showed
sensitivity and selectivity towards OPN (detection limit of 3.7 nM) and
was able to detect OPN in the presence of other interfering proteins,
with the exception of thrombin. The very low detection limit obtained
suggests the great potential of this aptasensor since OPN is usually pres-
ent in low concentrations in biological ﬂuids.
3.5.2. Aptasensors based on target binding-induced aptamer dissociation/
displacement
Another strategy for the design of electrochemical aptasensors is
based on the target-induced aptamer dissociation/displacement. This
strategy is grounded mainly in the strong afﬁnity of the label-free
aptamer to its speciﬁc target with a labelled aptamer-complementarysequence (Han et al., 2010). Upon binding of the target-aptamer, the
dissociation/displacement of the complementary sequences of the
aptamer occurs, which leads to the change of detectable signals. This
strategy was used to detect thrombin (Lu et al., 2008; Xiao et al.,
2005b). Xiao et al. (2005b) developed a “signal-on” aptasensor using
an aptamer immobilized onto a gold electrode and then hybridized
with a partially complementary DNA sequence labelled with MB.
Upon thrombin binding, the aptamer adopted a G-quadruplex confor-
mation and the labelled aptamer-cDNA sequence pushed MB closer to
the gold electrode surface, thus giving rise to a detectable current that
could be measured by ACV. This aptasensor allowed the detection of
thrombin in a linear concentration range up to 80 nMwith a detection
limit of 3 nM, which is quite good as compared to the previous exam-
ples. Lu et al. (2008) developed a “signal-off” aptasensor for the same
protein, using a Fc-labelled short aptamer-complementary DNA se-
quence to form dsDNA duplex with the aptamer immobilized on a
gold electrode. The target binding led to the dissociation of the label-se-
quence that was followed by a decrease in the DPV current signal due to
the distance between the Fc-label and the gold electrode. The
aptasensorwas found to be reusable andhighly speciﬁcwith a detection
limit of 2 nM.
Recently, Zhao et al. (2012) reported a label-free electrochemical
aptasensor for the simultaneous detection of two tumor markers,
MUC1 and VEGF that are associatedwith a poor prognosis and poor sur-
vival of the breast cancer patients. In this aptasensor, the Fc-labelled
aptamer-complementary DNA sequence was immobilized onto the
gold disk electrode that hybridizes with bothMUC1 and VEGF aptamers
to form a long double strand blocking the electrochemical signal. In the
presence of the two tumormarkers, the hybridization reaction between
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electrode surface, being the increase in the current detected by SWV.
This simple “signal-on” electrochemical aptasensor allowed the detec-
tion of the two markers and most importantly the discrimination of
their co-existence.
3.6. Use of nanomaterials in electrochemical aptasensors
In order to achieve highly sensitive electrochemical aptasensors,
several nanomaterials have been explored for the immobilization of
aptamers onto electrode surfaces and for signal transduction. Metal
nanoparticles (e.g. AuPNs, AgNPs, PtNPs), silica nanoparticles (Si NPs),
QDs, magnetic nanoparticles (MNPs), carbon nanotubes (CNTs),
graphene (GNs) and their nanocomposites have been used for the de-
velopment of electrochemical biosensors (Bai et al., 2012; Cao et al.,
2014; Chen et al., 2015; Deng et al., 2013b; Hu et al., 2014; Jo et al.,
2015; Li et al., 2011b; Ravalli et al., 2015; Wang et al., 2011; Zhao et
al., 2011a) These nanomaterials have unique physical and chemical
properties and can be used in several electrode surfaces such as GCE
(Ding et al., 2010; Li et al., 2011b) and SPE (Suprun et al., 2008) in a va-
riety of applications. For electrochemical applications, these
nanomaterials allowed an easy functionalization of the electrode sur-
faces, namely an increase of the surface area for the aptamers attach-
ment onto the electrode surfaces, therefore facilitating the access of
the target molecule to these aptamers, and acting as electrochemical la-
bels by increasing the signal ampliﬁcation or electron-transfer media-
tors (Citartan et al., 2012; Erdem et al., 2009; Hernandez and Ozalp,
2012; Palchetti and Mascini, 2012; Vidotti et al., 2011; Vikesland and
Wigginton, 2010; Wang et al., 2015). Taking into account these advan-
tages, the use of nanomaterials in the development of aptasensors will
lead to an increase in the sensitivity, i.e. in the detection of low levels
of protein biomarkers. However, this strategy can also enclose somedis-
advantages, such as complicated procedures, increased expenses,Table 3
Electrochemical aptasensors using voltammetric techniques for the detection of protein diseas
Target/aptamers Nanomaterials
Electrochemical
technique
Detection lim
(LOD)
Thrombin (DNA) NPs DPV 0.55 fM
Thrombin (DNA) AuMNPs and AuNPs DPV 30 fM
Thrombin (DNA) CdSe - QDs DPV 2.14 nM
Thrombin (DNA) GNs and AuNPs DPV 0.2 pM
Thrombin (DNA) GNs and NPs DPV 3.4 × 10−13 M
Thrombin (DNA) GNs-CS DPV 0.45 × 10−3
PDGF (DNA) AuNPs CV 1 × 10−14 M
(diluted)
1 × 10−12 M
(undiluted)
PDGF and thrombin
(DNA/DNA)
rGS-PtNPs and
AuNPs-SWCNTs
DPV 8 pM (PDGF)
11 pM (throm
PDGF (DNA) GNs and AuNPs CV 1.7 pM
MUC1 (DNA) AuNPs and MWCNTs DPV 2.2 nM
MUC1 (DNA) AuNPs and MWCNTs DPV 1 pM
Osteopontin (RNA) CB[7] and AuNPs SWV 164.62 pM
VEGF (DNA) AuNPs DPV 30 nM
VEGF (DNA) BSA-AuNCs DPV 0.32 pM
Note: AuMNPs (goldmagnetic nanoparticles); AuNPs (gold nanoparticles); CB[7] (Cucurbit[7]u
I); CV (cyclic voltammetry); DPV (differential pulse voltammetry); Fc-SiNPs (ferrocene-mod
MWCNTs (multi-walled carbon nanotubes); NCs (nanoclusters); NPs (nanoparticles); PDDA
polymer); PTCA (3,4,9,10-perylene tetracarboxylic acid); PtNPs (platinum nanoparticles); QD
nanotubes); SWV (square wave voltammetry); VEGF (vascular endothelial growth factor); u
and 65 kDa (osteopontin).decreased reproducibility and quantiﬁcation, especially when the use
of complex samples is envisaged (Palchetti and Mascini, 2012). Table
3 summarizes some studies that used nanomaterials to develop electro-
chemical aptasensors using voltammetric techniques for speciﬁc pro-
tein detection and disease diagnosis. It is important to mention that
the most recent reports on electrochemical aptasensors involve the
use of nanomaterials for their improvement, thus highlighting the rele-
vance of these approaches.
The use of AuNPs in aptasensors for the ampliﬁcation of the signal
and as a target recognition element has been described by Ding et al.
(2010). The authors used cadmium sulﬁde-quantum dots (CdS-QDs)
to modify the surface of AuNPs for the detection of thrombin. This strat-
egy greatly improved the aptasensor sensitivity comparing to other ex-
amples previously described, mainly due to the signal ampliﬁcation.
Wang et al. (2011) also reported amulti-ampliﬁcation aptasensor to de-
tect thrombin based on graphene matrix. The fabrication of this sand-
wich electrochemical aptasensor used: (i) hollow CoPt bimetal alloy
nanoparticles (HCoPt) and conjugated reduced graphene oxide sheets
(RGs), which allowed loading several redox probes as thionine (Thi),
HRP and secondary aptamer-2 (HCoPt-RGs-Thi-HRP) and (ii) GCE sur-
face modiﬁed with chitosan-hollow CoPt alloy nanoparticle (Cs-
HcoPt) ﬁlm activated with glutaraldehyde (GA) for the immobilization
of aptamer-1. This aptasensor, using CV and DPV techniques, presented
a low detection limit and a good speciﬁcity for thrombin, thus suggest-
ing that these approaches improve the aptasensors performance, dem-
onstrating the promising application of graphene for other protein
detection and disease diagnosis. Zhao et al. (2011a) reported another
example for thrombin detection based on the ampliﬁcation of
aptamer-AuNPs-HRP conjugates. The aptamer-1 was immobilized into
core/shell iron oxide/gold magnetic nanoparticles (Fe3O4-AuMNPs)
(capture probe) and the aptamer-2 was coupled with AuNPs and HRP
for signal ampliﬁcation (detection probe). The proposed sandwich elec-
trochemical aptasensor provided remarkable signal ampliﬁcation, duee biomarkers using nanomaterials.
it
Working range Application Reference
1.0–10 fM Thrombin detection in
real samples
Ding et al. (2010)
0.1–60 pM Thrombin detection Zhao et al.
(2011a)
80.21–347.59 nM and
37.4–828.88 nM
Thrombin detection Li et al. (2011b)
1 × 10−3–40 nM Thrombin detection Yuan et al. (2011)
1.0 × 10−12–5.0 × 10−8 M Thrombin detection Wang et al.
(2011)
pM 1 × 10−6–1 × 10−4 nM Thrombin detection Wang et al.
(2012)
n.d. PDGF detection in
puriﬁed samples
and undiluted
blood serum
Wang et al.
(2009)
bin)
0.01–35 nM (PDGF)
0.02–45 nM thrombin
PDGF and thrombin
detection
Bai et al. (2012)
5 × 10−3–60 nM PDGF detection Deng et al.
(2013b)
8.8–353.3 nM MUC1 detection Hu et al. (2014)
1–100 nM MUC1 detection Chen et al. (2015)
769.23 pM–7.69 nM Osteopontin detection Cao et al. (2014)
0–250 nM VEGF detection Ravalli et al.
(2015)
1–120 pM VEGF detection Shamsipur et al.
(2015)
ril substrate); CNTs (carbon nanotubes); CdSe (cadmium selenide); cTnI (cardiac troponin
iﬁed silica nanoparticles); GNs (graphene); MP (magnetic particles); MUC1 (Mucin 1);
(poly(diallyldimethylammonium chloride); PoPD (poly(o-phenylenediamine) functional
s (quantum dots); rGS (reduced graphene oxide sheets); SWCNTs (single-walled carbon
nits converted to Molar taking into account the molecular weight 37.4 kDa (thrombin)
951S.G. Meirinho et al. / Biotechnology Advances 34 (2016) 941–953to the AuNPs and catalytic reaction of HRP, showing a detection limit of
30 fM, obtained by applying DPV technique.
This recent use of nanomaterials also enabled the development of
some aptasensors for the electrochemical detection of proteins associat-
ed with breast cancer. Cao et al. (2014) reported a label-free electro-
chemical aptasensor for OPN using a strategy that does not require the
aptamers immobilization on the electrode surface. This strategy in-
cludes: (i) the electrode functionalization using AuNPs and
cucurbit[7]uril which, allows an efﬁcient capture of MB tag and (ii)
the OPN target binding to RNA aptamer (R3-OPN) (Mi et al., 2009) by
an exonuclease-catalyzed digestion of the aptamer-cDNA sequence
modiﬁed with MB-labelled, which acts as a signaling molecule. In the
absence of OPN, the structure formed between the aptamer and
aptamer-cDNA sequence prevent the degradation of the cDNA-se-
quence by Exo-I digestion. Upon, aptamer-OPN interaction, the cDNA-
sequence-MB-labelled will be liberated and susceptive to Exo-I action
leading to the digestion of the cDNA sequence, allowing the MB tag to
be captured by cucurbit[7]uril immobilized on the electrode, resulting
in an electrochemical signal, detectable by SWV. This aptasensor pre-
sented high speciﬁcity, good reproducibility and a detection limit of
10.7 ng/mL. These results are of utmost relevance to support the devel-
opment of new biosensors able to detect and quantify OPN in biological
samples and can be apply for the detection of multiple proteins, by
modifying different cDNA-sequences with different tags. Hu et al.
(2014) developed an ultrasensitive electrochemical aptasensor for the
detection of MUC1, which is as mentioned before a useful marker for
breast cancer. In the fabrication of this aptasensor, AuNPs and the en-
zyme HRP were used with labels and a GCE electrode was modiﬁed
with multi-walled carbon nanotubes and streptavidin. The aptamer
was modiﬁed with thiol at the 5´-end and with biotin at the 3′-end.
The modiﬁed aptamer and HRP were then immobilized on the AuNPs
(APT-AuNPs-HRP), allowing the bridges between the aptamer and the
enzyme (HRP) to increase the signal ampliﬁcation. After the aptamer-
MUC1 interaction, the aptamer was disrupted and the biotin exposed
was captured by the streptavidin-modiﬁed electrode. This “signal-on”
aptasensor exhibited good linear correlation dynamic ranges from
8.8 nM to 353.3 nM and a very low detection limit (2.2 nM). Likewise,
Chen et al. (2015) also reported a signal-on electrochemical aptasensor
for the same protein. The poly(o-phenylenediamine)-AuNPs (PoPD-
AuNPs) ﬁlm was used as capture probe for the immobilization of
aptamer-1. On the other hand, the AuNPs functionalized silica/multi-
walled carbon nanotubes core-shell nanocomposites (AuNPs/SiO2@
MWCNTs) were used to enhance the surface area for immobilizing the
secondary aptamer, as well as to load large amounts of electrochemical
probe thionine (Thi). The presence of MUC1 induced the formation of
one complex between the PoPD-AuNPs-APT1 and the Thi-AuNPs/
SiO2@MWCNTs-APT2. The current changes that resulted from the for-
mation of such complex were registered by DPV and a detection limit
of 1 pM was obtained. In comparison with the work carried out by
Zhao et al. (2012) and Hu et al. (2014), this aptasensor showed better
linear range and detection limit, since the AuNPs andMWCNTs facilitate
electron transfer from Thi to electrode. For the detection and analysis of
VEGF (biomarker associatedwith different types of cancer), Ravalli et al.
(2015) reported an electrochemical single-use aptasensor. The pro-
posed aptasensor was based on a sandwich assay using two different
aptamers, AuNPs and an enzyme-ampliﬁed detection. The graphite
screen-printed electrodes (GSPEs) were modiﬁed by electrodeposition
of AuNPs for thiolated aptamer-1 immobilization. After aptamer-1-
VEGF recognition, the biotinylated aptamer 2 was added and the
resulting complex was coupled with streptavidin-alkaline phosphatase
for ampliﬁeddetection. The electroactive product of the enzymatic reac-
tion was detected by means of DPV. The “signal-on” aptasensor re-
sponse was found to be linearly related to the target concentration
between 0 and 250 nM; the detection limit was 30 nM, which was
slightly worse than the examples previously mentioned. Shamsipur et
al. (2015) also reported a label-free “signal-off” aptasensor to detectVEGF but using a BSA-gold nanocluster/ionic liquid as platform, which
offers a large surface area to immobilize the aptamer. Upon binding of
the protein, a decrease in the current intensity was observed, mainly
due to the target-induced folding of the aptamer, leading to a detection
limit of 0.32 pM, which is much lower than the works reported by
Ravalli et al. (2015) and Zhao et al. (2011b) possibly due to application
of nanoclusters stabilized by BSA protein, which allow a large speciﬁc
surface area, easy functionalization, low toxicity and good conductivity.
For the detection of PDGF, another protein disease biomarker, Wang et
al. (2009) described an electrochemical approach using a sandwich
assay. The authors used AuNPs to increase the signal of the electrochem-
ical probe. Using this approach, the sensitivity of the aptasensor was
greatly increased allowing the detection of PDGF both in puriﬁed sam-
ples and in undiluted blood serum. Deng et al. (2013a,b) also developed
an aptasensor to detect PDGF but using the enzyme-mediated direct
electrochemistry of glucose oxidase (GOD). The GOD layer was adsorbed
onto the electrode surface using a poly(diallyldimethylammonium chlo-
ride) (PDDA)-protected graphene-gold nanoparticles (P-Gra-AuNPs)
composite and the aptamer was immobilized onto the gold nanoclusters
(GNCs) deposited on the surface of GOD. This aptasensor showed high
sensitivity and speciﬁcity for PDGF, as well as a very good reproducibility
and stability.
Based in a dual signal ampliﬁcation strategy, Bai et al. (2012) report-
ed a sandwich assay for the simultaneous detection of PDGF and throm-
bin. The aptasensor was fabricated using AuNPs functionalized single-
walled carbon nanotubes (AuNPs@SWCNTs) as the biosensor platform
to capture a large amount of primary aptamers and amplify the detec-
tion response. The redox probes toluidine blue (Tb) and Fc were at-
tached onto the reduced graphene oxide sheets (rGS) coated with
PtNPs (PtNPs-redox probes-rGS nanocomposites). The synthesized
PtNPs-Tb/Fc-rGS nanocompositeswere then used as carriers for glucose
oxidase (GOD) and horseradish peroxidase (HRP) and the aptamer-2
(PDGF- and thrombin-binding), respectively. The linear range of PDGF
was found to be 0.01 to 35 nM with a detection limit of 8 pM, while
the linear range was 0.02 to 45 nM with a detection limit of 11 pM for
thrombin as obtained by DPV. The results clearly demonstrate that
these dual signal ampliﬁcation strategies lead to very low detection
limits as compared to the previously discussed strategies (Sections 3.4
and 3.5).
Altogether, these studies highlight that the use of nanomaterials in
the development of aptasensors allows an improvement of the sensibil-
ity in the detection of speciﬁc proteins (e.g. OPN, MUC1, PDGF and
VEGF) and can hold a great promise for point-of-care diagnosis of genet-
ic diseases and for the detection of cancer.
4. Conclusions
In the recent years, there has been an increasing interest in the use of
aptasensors for the detection of protein disease biomarkers employing
different immobilization techniques, design strategies andmodes of de-
tection. However, most of these aptasensors have been developed for in
vitro detection of biomarkers, therefore the design of in vivo solutions
should be a priority in the future.
The majority of cancer diseases are associated with the presence of
more than one protein biomarker. Hence, further developments on
the aptasensors ﬁeld must involve the design of multiple detection sen-
sors for different or even the same biomarkers, as these substances can
be found in very low amounts in biological ﬂuids. Multiple detection
sensors would increase sensitivity and consequently provide more ac-
curate information on biomarkers levels, thus improving the prognosis
and treatment of diseases. The aptasensors arrays can be a good alterna-
tive offering the possibility of simultaneous measurements of a variety
of targets, and thus shortening the time required for the analysis and de-
creasing the detection costs. Another alternative is the use ofmicrochips
and nanochips to allow miniaturization and integration of
nanomaterials that enhance the surface area, as well as for signal
952 S.G. Meirinho et al. / Biotechnology Advances 34 (2016) 941–953ampliﬁcation in the development of electrochemical aptasensors. How-
ever, the simultaneous detection of multiple targets (e.g. protein bio-
markers) using voltammetric aptasensors arrays has seldom been
reported.
The future of aptamer-based biosensors looks increasingly bright,
yet many hurdles, such as lack of speciﬁc aptamers against protein bio-
markers, lack of experience inmulti-analyte detection and the complex-
ity of clinical samples, remain to be solved especially in the ﬁeld of
biomedicine and point-of-care diagnostics.
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